|
The North American Neuromodulation Society (NANS), alongside leading national pain and spine organizations, has submitted a joint comment letter to National Government Services (NGS) regarding its proposed Local Coverage Determination (LCD) for thermal destruction of the intraosseous basivertebral nerve (BVN) to treat vertebrogenic low back pain.
0 Comments
As part of its ongoing efforts to protect patient access to evidence-based therapies, NANS has submitted a formal comment letter to Cigna regarding Medical Coverage Policy 0539, which currently classifies Peripheral Nerve Stimulation (PNS) as "not medically necessary."
NANS Members: Visit the NANS eLearning platform to download a workbook with full details of how Medicare changes affect neuromodulation, pain, evaluation and management and telemedicine in 2026.
NANS Joins National Effort Urging CMS to Reverse Proposed Limits on Peripheral Nerve Blocks12/9/2025 The North American Neuromodulation Society (NANS) has joined a coalition of national and state medical societies in responding to CMS’ proposed Local Coverage Determinations (LCDs) that would sharply restrict coverage for peripheral nerve blocks (PNBs) and other established chronic pain procedures.
The North American Neuromodulation Society (NANS) has joined a broad coalition of national medical societies in signing a letter urging Elevance Health (Anthem) to rescind its new Facility Administrative Policy: Use of a Nonparticipating Care Provider, set to take effect January 1, 2026, in 11 states.
NANS 2026 Sets Record Number of Scientific Abstracts — Advancing ‘From Discovery to Healing’11/13/2025 The North American Neuromodulation Society (NANS) has accepted 478 abstract submissions, including 312 scientific abstracts, for its 2026 Annual Meeting, taking place January 22–25, 2026, at Caesars Palace in Las Vegas—the highest number in recent years. NANS also accepted 160 case reports/small series and 6 late-breaking abstracts, surpassing 2025 totals and underscoring continued growth in the field.
The Centers for Medicare & Medicaid Services (CMS) has released the 2026 Medicare Physician Fee Schedule (MPFS) Final Rule, effective January 1, 2026, introducing a new –2.5% “efficiency adjustment” that will reduce reimbursement for many surgical and procedural specialties.
The North American Neuromodulation Society (NANS) has joined seven national medical specialty societies in signing a joint letter urging Blue Cross Blue Shield of Illinois, Montana, New Mexico, Oklahoma, and Texas—as well as the Health Care Services Corporation—to revise their draft policy on implantable peripheral nerve stimulation (PNS) for chronic pain.
Several Medicare Administrative Contractors (MACs) have released proposed Local Coverage Determinations (LCDs) that would classify peripheral nerve blocks and radiofrequency ablation (RFA) procedures—including genicular, shoulder, and hip—as “not reasonable and necessary."
|
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
March 2026
Categories |
RSS Feed